Medtronic (NYSE: MDT) today announced the first results from the high cardiovascular risk cohort of its SPYRAL AFFIRM study.

The Medtronic award is part of $17 million in tax incentives the state of Massachusetts recently announced for 25 life ...

On August 19th, Medtronic released its earnings report for the fiscal first quarter ended July 25th, 2025. The company's ...

If you can't get on board with a volatile growth stock, what about a surgical robotics company that is just two years shy of ...

If you shift your view and look at it as a turnaround stock, it could be worth buying. The high yield, in this case, is ...

The Flinn Foundation recently released the latest version of its Bioscience Roadmap for Arizona — a guide to the sector in ...

Lab-grown seafood, a new treatment for Parkinson's disease and a kid-safe power saw are among the genius ideas from UC ...

An article published in Science by UBC researchers at Neuroethics Canada proposes a no-fault compensation scheme in the face ...

Wall Street feels these five Dividend Aristocrat stocks are the best values in the group and offer the best entry points for investors seeking dependable income with growth potential.

Medical device firms discussed privacy, regulations and prioritizing projects as AI becomes more prevalent in the industry.